ReviewmBio2026
Immunomodulatory functions of fungal melanins in respiratory infections.
Review in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Putative Multicopper Oxidase Encoded byInternational journal of molecular sciences · 2026Article
- Ustiloxins and Ustilaginoidins in the Sclerotia Generated from Rice False Smut Balls and Their Contents.Toxins · 2026Article
- Dynamic Reprogramming of Fungal Cell Walls Underlies Germination and Immune Exposure in Zygomycetous Fungal Pathogens.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The rate of invasive fungal infections has risen drastically over the last decade and continues to carry devastatingly high mortality rates. Currently, there are no licensed vaccines and limited antifungal agents in clinical trials for fungal-mediated diseases. The limited effectiveness of FDA-approved antifungal medications against invasive fungal infections and the lack of mechanistic understanding of how these infections manifest pose a significant burden on healthcare systems worldwide. Therefore, understanding the molecular details of the host-fungal interactions has never been more urgent. Here, we examine the role of fungal melanin as a virulence factor through its immunomodulatory effects during respiratory infections. Although previous literature on fungal pathogenicity has touched briefly on fungal pigments, they are incomplete in discussing how melanin dysregulates essential functions of the innate immune system. To provide a contemporary perspective, literature on melanized fungal species commonly associated with infections via the respiratory tract has been reviewed to detail holistic mechanisms by which melanin subverts the immune system and manipulates the respiratory epithelium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.